Nexus NeuroTech Ventures
Overview
Nexus NeuroTech Ventures is a venture capital firm founded in 2023, committed to advancing breakthrough technologies for brain disorders. The firm focuses on investing in companies developing innovative solutions for neurodegenerative, neuropsychiatric, and neurodevelopmental disorders, including Parkinson’s disease, bipolar disorder, and autism spectrum disorder. Their investment approach spans a range of technologies, from less invasive to more invasive medical treatments, software and hardware-based diagnostic tools, data platforms supporting clinical trials and care, and tools aimed at advancing therapy development and optimizing clinical care. The firm's investment strategy targets companies with compelling technology and promising initial human data, enabling their successful technological and business development, as well as clinical evidence generation and market access. Nexus NeuroTech Ventures also offers an incubator program to nurture promising neurotechnology initiatives that require additional technical refinement, preliminary clinical evidence generation, and guidance before they are prepared for conventional venture capital backing. The team at Nexus NeuroTech Ventures brings together leaders in neurotechnology, clinical neuroscience, and biomedical engineering, including co-founders Dr. Jordi Parramon and Dr. William Marks. Their combined expertise allows the firm to identify and accelerate technology solutions that address patients’ needs along their journeys, aiming to bring impactful solutions to people affected by neurological disorders or psychiatric conditions.
Investment Focus
- Innovative technologies addressing brain disorders
- Promising initial human data
- Potential for successful technological and business development
- Ability to generate clinical evidence and achieve market access
- Alignment with Nexus NeuroTech Ventures' mission and focus areas
Portfolio Companies
Reach Nexus NeuroTech Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Nexus NeuroTech Ventures
What sectors does Nexus NeuroTech Ventures invest in?
Nexus NeuroTech Ventures invests in Healthcare, HealthTech, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in San Francisco, United States. Nexus NeuroTech Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Nexus NeuroTech Ventures invest at?
Nexus NeuroTech Ventures backs companies at Seed, Series A and Series B, writing cheques of 1M - 50M.
Which regions does Nexus NeuroTech Ventures invest in?
Nexus NeuroTech Ventures invests across United States.
Who are the partners at Nexus NeuroTech Ventures?
Team members listed for Nexus NeuroTech Ventures include Jon Lundt (Principal) and John Propst (Principal).
What companies has Nexus NeuroTech Ventures invested in?
Nexus NeuroTech Ventures's portfolio includes InSightec, Rune Labs, Ampa Health, Beacon Biosignals, Cala Health, Cortica, EarliPoint Health and Modulight.Bio.
How do I contact Nexus NeuroTech Ventures?
Nexus NeuroTech Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
